Therapeutic Asset Ratings
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
VINBLASTINE
Lymphoma
Intensity Therapeutics, Inc.
P4
BBB
(72)
(+)-VINCRISTINE
ALK-Negative Anaplastic Large Cell Lymphoma
Shanghai Jiao Tong University School of Medicine
P4
BBB
(72)
(+)-VINCRISTINE
Burkitt Lymphoma
AIDS Malignancy Consortium
P4
BBB
(72)
(+)-VINCRISTINE
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.
P4
BBB
(72)
(+)-VINCRISTINE
Primary Mediastinal Large B-Cell Lymphoma
Sun Yat-sen University
P4
BBB
(72)
VINDESINE
Lymphoblastic Lymphoma
University Hospital Muenster
P4
BBB
(72)
ZINC D-GLUCONATE (1:2)
Wilson Disease
Jun Li
P4
BBB
(72)
Zoster Vaccine Recombinant, Adjuvanted
Herpes Zoster
GlaxoSmithKline
P4
BBB
(72)
ASPARAGINASE
Childhood Acute Lymphoblastic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
P3
BBB
(72)
Blinatumomab
Precursor B-Cell Acute Lymphoblastic Leukemia
Amgen
P3
BBB
(72)
Blinatumomab
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Novartis Pharmaceuticals
P3
BBB
(72)
Brentuximab Vedotin
Anaplastic Large Cell Lymphoma
Seagen Inc.
P3
BBB
(72)
Brexpiprazole
Alzheimer Disease
Otsuka Pharmaceutical Co., Ltd.
P3
BBB
(72)
Carboplatin
Estrogen-Receptor Negative Breast Cancer
Northwestern University
P3
BBB
(72)
Carboplatin
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Lung Adenocarcinoma
Guangdong Association of Clinical Trials
P3
BBB
(72)
Carboplatin
Ovarian Clear Cell Adenocarcinoma
NRG Oncology
P3
BBB
(72)
Carboplatin
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Ovarian Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Primary Peritoneal Serous Adenocarcinoma
National Cancer Institute (NCI)
P3
BBB
(72)
Carboplatin
Progesterone-Receptor Negative Breast Cancer
Northwestern University
P3
BBB
(72)
Showing 876 to 900 of 42,334 assets
Previous
Page 36 of 1694
Next